http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9945932-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b328bdcbe6561ead7e1abf17a09be11c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29d9e0d38217fd5cef1b25e772a8c87a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_079b159056b6ab69eba0454701221ca2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
filingDate 1999-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b62c665ad38352dc7843732ebc3cf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6145d60cd432d235e3904f20a186848a
publicationDate 1999-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9945932-A1
titleOfInvention Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method
abstract The invention concerns a pharmaceutical composition based on natural synthesis progesterone and oestradiol in tablet form, characterised in that its disintegration time is less than 15 minutes, preferably less than 10 minutes, and more preferably less than 5 minutes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6866865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6544553-B1
priorityDate 1998-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9505807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4755386-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0371466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5633242-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9848782-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135908340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129479675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129844352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412118

Total number of triples: 40.